Adial Pharmaceuticals, Inc. (ADIL )

Currency in USD Disclaimer
$5.05 +$1.34 (36.12%)
Closed 10/28/2026
$3.82
$5.2
$1.31
$10.75

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol ADIL
  • Company Adial Pharmaceuticals, Inc.
  • Price $5.05
  • Changes Percentage 36.12
  • Change 1.34
  • Day Low $3.82
  • Day High $5.2
  • Year High $10.75
  • Year Low $1.31
  • Market Cap $4,260,819
  • Price Avg 50 EMA (D) $4.58
  • Price Avg 200 EMA (D) $3.56
  • Exchange NASDAQ
  • Volume 47,184
  • Average Volume 59,898
  • Open $3.83
  • Previous Close $3.71
  • EPS -16.54
  • PE -0.27
  • Earnings Announcement 2026-11-18 12:00:00
  • Shares Outstanding $959,644

Company brief: ADIAL PHARMACEUTICALS, INC. (ADIL )

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

ADIL Corporation News

Income Statement